Skip to main content
SB18-022

Clinical Practice For Opioid Prescribing

Type Bill
Session 2018 Regular Session
Subjects
Health Care & Health Insurance

Concerning clinical practice measures for safer opioid prescribing.

Bill Summary:

Health care practitioners - prescriptive authority - opioids - prescribing restrictions - required use of prescription drug monitoring program - report - repeal. The act restricts the number of opioid pills that a health care practitioner, including physicians, physician assistants, advanced practice nurses, dentists, optometrists, podiatrists, and veterinarians, may prescribe for an initial prescription to a 7-day supply and allows each health care practitioner to exercise discretion to include a second fill for a 7-day supply. The limit on initial prescribing does not apply if, in the judgment of the health care practitioner, the patient:

  • Has chronic pain that typically lasts longer than 90 days or past the time of normal healing, as determined by the health care practitioner, or following transfer of care from another practitioner who prescribed an opioid to the patient;
  • Has been diagnosed with cancer and is experiencing cancer-related pain; or
  • Is experiencing post-surgical pain that, because of the nature of the procedure, is expected to last more than 14 days.
Additionally, a physician, a physician assistant, and an advanced practice nurse is not subject to the prescription limits if the patient is undergoing palliative or hospice care. The restrictions on opioid prescriptions repeal on September 1, 2021.

The act requires a health care practitioner to indicate his or her specialty or practice area upon making an initial query to the prescription drug monitoring program and to query the program prior to prescribing the second fill for an opioid unless the person receiving the prescription meets certain requirements.

The act requires the department of public health and environment to report to the general assembly its findings from studies regarding the prescription drug monitoring program conducted pursuant to a federal grant program. The act also requires the department to forward its findings to the center for research into substance use disorder prevention, treatment, and recovery support strategies at the university of Colorado health sciences center for training purposes.


(Note: This summary applies to this bill as enacted.)

Status

Became Law

Introduced

Passed

Became Law

Related Documents & Information

Date Version Documents
05/21/2018 Signed Act PDF
05/16/2018 Final Act PDF
05/07/2018 Rerevised PDF
05/04/2018 Revised PDF
02/22/2018 Reengrossed PDF
02/21/2018 Engrossed PDF
01/10/2018 Introduced PDF
Date Version Documents
05/04/2018 PA2 PDF
02/09/2018 PA1 PDF
Date Version Documents
08/03/2018 FN3 PDF
03/21/2018 FN2 PDF
01/25/2018 FN1 PDF
Activity Vote Documents
Adopt amendment L.019 [Attachment A]. The motion passed without objection. Vote summary
Adopt amendment L.020 [Attachment B]. The motion passed without objection. Vote summary
Refer Senate Bill 18-022, as amended, to the Committee of the Whole. The motion passed on a vote of 9-4. Vote summary
Activity Vote Documents
Adopt amendment L.005 (Attachment A). The motion passed without objection. Vote summary
Refer Senate Bill 18-022, as amended, to the Committee of the Whole. The motion passed on a vote of 5-0. Vote summary
Date Calendar Motion Vote Vote Document
05/07/2018 Third Reading BILL
40
AYE
25
NO
0
OTHER
Vote record
Date Calendar Motion Vote Vote Document
05/07/2018 House Amendments REPASS
29
AYE
6
NO
0
OTHER
Vote record
05/07/2018 House Amendments CONCUR
34
AYE
1
NO
0
OTHER
Vote record
02/22/2018 Third Reading BILL
29
AYE
6
NO
0
OTHER
Vote record
Date Location Action
05/21/2018 Governor Governor Signed
05/16/2018 Governor Sent to the Governor
05/16/2018 House Signed by the Speaker of the House
05/15/2018 Senate Signed by the President of the Senate
05/07/2018 Senate Senate Considered House Amendments - Result was to Concur - Repass
05/07/2018 House House Third Reading Passed - No Amendments
05/04/2018 House House Second Reading Special Order - Passed with Amendments - Committee
05/03/2018 House House Committee on Health, Insurance, & Environment Refer Amended to House Committee of the Whole
02/23/2018 House Introduced In House - Assigned to Health, Insurance, & Environment
02/22/2018 Senate Senate Third Reading Passed - No Amendments
02/21/2018 Senate Senate Second Reading Passed with Amendments - Committee
02/14/2018 Senate Senate Second Reading Laid Over to 02/16/2018 - No Amendments
02/13/2018 Senate Senate Second Reading Laid Over Daily - No Amendments
02/08/2018 Senate Senate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole
01/10/2018 Senate Introduced In Senate - Assigned to Health & Human Services
Effective Date Chapter # Title Documents
05/21/2018 221 Clinical Practice For Opioid Prescribing PDF